New Ray Medicine International Holding Limited 新銳醫藥國際控股有限公司

SFC sues New Ray Medicine (6108) and its former top executives
SFC, 30-Nov-2020
NRM is a company in our "Enigma Network".
A New Ray of light on an Enigma Network case
A decision quietly posted on the SFAT website reveals that Zhou Ling, ex-Chairman of New Ray Medicine (6108) is suspected by the SFC to have committed "misconduct and obtained secret profits from certain transactions" by NRM. Earlier gazetted Restriction Notices on a client at 2 brokers now make sense - the SFC has reduced disclosure in that area so much as to make the publication meaningless. (26-Oct-2020)
SFC issues restriction notices to two brokerages to freeze accounts of client involved in suspected corporate misconductRestriction Notices
SFC, 14-Aug-2020
There's no disclosure of the listed company involved. Our database records that both of the brokers acted as placing agents to companies in the "Enigma Network" up to 2016. The brokers are not under investigation, but an individual client is suspected of breaching his duties to a listed company. The Notices are remarkably brief, no longer referring to a "Statement of Reasons", which the SFC has stopped publishing anyway, probably because we kept figuring out the identities of persons involved. The "specified amount" involved is not disclosed either.
SFC suspends China Wah Yan Healthcare (0648)
SEHK, 27-Nov-2017
Another member of the Enigma Network. 4 of the 50 stocks have now been suspended by the SFC. This follows First Credit Finance (8215) on 24-Nov-2017, New Ray Medicine (6108) on 6-Oct-2017 and Lerado (1225) on 6-Jun-2017.
SFC directs suspension of New Ray Medicine (6108)Enigma Network
Company announcement, 6-Oct-2017
This was one of the 50 stocks not to own in our "Enigma Network" published on 15-May-2017.
The Enigma Network: 50 stocks not to own
Sometimes, all you need to tell a story is a picture. (15-May-2017)
Finsoft (8018) sells 5% of C&C International Healthcare Group Ltd to New Ray Medicine (6108) for HK$25.5mNRM announcement
Company announcement, 16-Mar-2017
New Ray Medicine (6108) buys 39% of C&C International Healthcare Group Ltd for HK$189.31m
Company announcement, 18-Oct-2016
The first 9% does not require shareholders' approval but the second tranche does. NRM fails to say who owns the rest of the target or who owns the vendor, JFA Capital, but we can tell you JFA Capital is 49.5% owned by Convoy (1019). JFA has already sold 4% to Rui Kang Pharmaceutical (8037) and 5% to Finsoft (8018), both in July.
China Wah Yan (0648) buys 9.9% of New Ray Medicine (6108) at 265% above market
Company announcement, 23-Jun-2016
The BVI vendor is not named, nor is its owner, but we can tell you the vendor is owned by Town Health (3886) which cut its stake from 14.38% to 4.38%.
New Ray Medicine (8180): allotments and concentration warning
Company announcement, 24-Oct-2013

Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top